J B Chemicals & Pharmaceuticals Ltd. - Research Center
506943 JBCHEPHARM Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 2,884.16 | 2,189.88 | 1,892.00 | 1,640.74 | 1,501.19 |
| Operating profit | 664.69 | 508.91 | 556.37 | 368.24 | 287.99 |
| Interest | 34.31 | 4.95 | 7.19 | 2.94 | 4.12 |
| Gross profit | 639.03 | 542.57 | 661.06 | 414.65 | 324.10 |
| EPS (Rs) | 25.12 | 23.36 | 28.93 | 17.35 | 11.35 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 8.65 | 38.61 | 111.89 | 49.34 | 40.23 |
| Stock adjustment | -27.48 | -25.57 | -15.70 | 2.53 | -21.66 |
| Raw material | 783.78 | 601.87 | 542.17 | 452.10 | 453.75 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 499.95 | 399.06 | 305.98 | 293.78 | 257.98 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 963.22 | 705.61 | 503.19 | 524.09 | 523.12 |
| Provisions made | - | - | - | - | - |
| Depreciation | 111.99 | 71.28 | 67.36 | 65.09 | 54.82 |
| Taxation | 138.15 | 110.29 | 146.62 | 71.42 | 87.22 |
| Net profit / loss | 388.89 | 361.00 | 447.08 | 268.14 | 182.06 |
| Extra ordinary item | - | - | - | -10.00 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 15.48 | 15.46 | 15.46 | 15.46 | 16.05 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 23.05 | 23.24 | 29.41 | 22.44 | 19.18 |
| GPM (%) | 22.09 | 24.35 | 32.99 | 24.53 | 21.03 |
| NPM (%) | 13.44 | 16.20 | 22.31 | 15.87 | 11.81 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis